+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative meta-analysis of 6 statin and 9 non-statin coronary regression trials Evidence that cholesterol lowering is the key to outcomes



Comparative meta-analysis of 6 statin and 9 non-statin coronary regression trials Evidence that cholesterol lowering is the key to outcomes



Circulation 94(8 Suppl. ): I579




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030621687

Download citation: RISBibTeXText


Related references

Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment. Pharmacogenetics and Genomics 23(10): 518-525, 2013

Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy. American Journal of Cardiology 105(9): 1289-1296, 2010

Lack of Effect of Lowering Ldl Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy. Yearbook of Endocrinology 2012: 84-86, 2012

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. Plos one 7(1): E29849, 2012

Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials. European Heart Journal 39(14): 1172-1180, 2018

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380(9841): 581-590, 2012

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet. Diabetes and Endocrinology 4(10): 829-839, 2016

Does cholesterol lowering induce retardation of progression or even regression of coronary artery disease? a meta analysis of the angiographic coronary regression trials. European Heart Journal 13(ABSTR Suppl.): 161, 1992

The effect of statin therapy on plaque regression following acute coronary syndrome: a meta-analysis of prospective trials. Coronary Artery Disease 27(8): 636-649, 2016

Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials. Heart 93(8): 914-921, 2007

Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome. Chinese Medical Journal 122(6): 659-664, 2009

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91(10): 2528-2540, 1995

Adverse Events of Statin-Fenofibrate Therapy versus Statin Alone A Meta-analysis of Randomized Controlled Trials. 2013

Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials. Clinical and Experimental Pharmacology and Physiology 40(3): 219-226, 2013

Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials. Current Medical Research and Opinion 29(3): 181-188, 2013